MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$3,222,892
(79.78%↑ Y/Y)
Loss before
provision for income taxes
-$3,222,892
Net revenue
$28,353
Loss from operations
-$1,646,169
Total other expense,
net
-$1,576,723
(-309.70%↓ Y/Y)
Gross margin
$5,750
Change in fair value of
derivative liabilities and...
$251,807
(365.29%↑ Y/Y)
Cost of revenue
$22,603
Interest income
$5,009
Total operating
expenses
$1,651,919
(-89.38%↓ Y/Y)
Interest expense
$1,595,315
(450.24%↑ Y/Y)
Loss on
extinguishment of debt
$238,224
General and
administrative (including...
$1,020,457
(-93.23%↓ Y/Y)
Sales and marketing
$334,739
(52.27%↑ Y/Y)
Research and development
$296,723
(12.78%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aspire Biopharma Holdings, Inc. (ASBPW)
Aspire Biopharma Holdings, Inc. (ASBPW)